Literature DB >> 27480339

Optimal treatment regimes for survival endpoints using a locally-efficient doubly-robust estimator from a classification perspective.

Xiaofei Bai1, Anastasios A Tsiatis2, Wenbin Lu2, Rui Song2.   

Abstract

A treatment regime at a single decision point is a rule that assigns a treatment, among the available options, to a patient based on the patient's baseline characteristics. The value of a treatment regime is the average outcome of a population of patients if they were all treated in accordance to the treatment regime, where large values are desirable. The optimal treatment regime is a regime which results in the greatest value. Typically, the optimal treatment regime is estimated by positing a regression relationship for the outcome of interest as a function of treatment and baseline characteristics. However, this can lead to suboptimal treatment regimes when the regression model is misspecified. We instead consider value search estimators for the optimal treatment regime where we directly estimate the value for any treatment regime and then maximize this estimator over a class of regimes. For many studies the primary outcome of interest is survival time which is often censored. We derive a locally efficient, doubly robust, augmented inverse probability weighted complete case estimator for the value function with censored survival data and study the large sample properties of this estimator. The optimization is realized from a weighted classification perspective that allows us to use available off the shelf software. In some studies one treatment may have greater toxicity or side effects, thus we also consider estimating a quality adjusted optimal treatment regime that allows a patient to trade some additional risk of death in order to avoid the more invasive treatment.

Entities:  

Keywords:  Classification; Doubly-robust; Observational survival study; Optimal treatment regime; Value search

Mesh:

Year:  2016        PMID: 27480339      PMCID: PMC5288304          DOI: 10.1007/s10985-016-9376-x

Source DB:  PubMed          Journal:  Lifetime Data Anal        ISSN: 1380-7870            Impact factor:   1.588


  11 in total

1.  Dynamic regime marginal structural mean models for estimation of optimal dynamic treatment regimes, Part I: main content.

Authors:  Liliana Orellana; Andrea Rotnitzky; James M Robins
Journal:  Int J Biostat       Date:  2010       Impact factor: 0.968

2.  Demystifying optimal dynamic treatment regimes.

Authors:  Erica E M Moodie; Thomas S Richardson; David A Stephens
Journal:  Biometrics       Date:  2007-06       Impact factor: 2.571

3.  Estimation and extrapolation of optimal treatment and testing strategies.

Authors:  James Robins; Liliana Orellana; Andrea Rotnitzky
Journal:  Stat Med       Date:  2008-10-15       Impact factor: 2.373

4.  Reinforcement learning design for cancer clinical trials.

Authors:  Yufan Zhao; Michael R Kosorok; Donglin Zeng
Journal:  Stat Med       Date:  2009-11-20       Impact factor: 2.373

5.  Doubly-robust estimators of treatment-specific survival distributions in observational studies with stratified sampling.

Authors:  Xiaofei Bai; Anastasios A Tsiatis; Sean M O'Brien
Journal:  Biometrics       Date:  2013-10-11       Impact factor: 2.571

6.  EFFECTIVELY SELECTING A TARGET POPULATION FOR A FUTURE COMPARATIVE STUDY.

Authors:  Lihui Zhao; Lu Tian; Tianxi Cai; Brian Claggett; L J Wei
Journal:  J Am Stat Assoc       Date:  2013-01-01       Impact factor: 5.033

7.  A robust method for estimating optimal treatment regimes.

Authors:  Baqun Zhang; Anastasios A Tsiatis; Eric B Laber; Marie Davidian
Journal:  Biometrics       Date:  2012-05-02       Impact factor: 2.571

8.  Targeted Learning of the Mean Outcome under an Optimal Dynamic Treatment Rule.

Authors:  Mark J van der Laan; Alexander R Luedtke
Journal:  J Causal Inference       Date:  2015-03

9.  A generalized estimator of the attributable benefit of an optimal treatment regime.

Authors:  Jason Brinkley; Anastasios Tsiatis; Kevin J Anstrom
Journal:  Biometrics       Date:  2009-06-09       Impact factor: 2.571

10.  Estimating Optimal Treatment Regimes from a Classification Perspective.

Authors:  Baqun Zhang; Anastasios A Tsiatis; Marie Davidian; Min Zhang; Eric Laber
Journal:  Stat       Date:  2012-01-01
View more
  11 in total

1.  ON ESTIMATION OF THE OPTIMAL TREATMENT REGIME WITH THE ADDITIVE HAZARDS MODEL.

Authors:  Suhyun Kang; Wenbin Lu; Jiajia Zhang
Journal:  Stat Sin       Date:  2018-07       Impact factor: 1.261

2.  Comment.

Authors:  Jingxiang Chen; Yufeng Liu; Donglin Zeng; Rui Song; Yingqi Zhao; Michael R Kosorok
Journal:  J Am Stat Assoc       Date:  2016-10-18       Impact factor: 5.033

3.  Improved precision in the analysis of randomized trials with survival outcomes, without assuming proportional hazards.

Authors:  Iván Díaz; Elizabeth Colantuoni; Daniel F Hanley; Michael Rosenblum
Journal:  Lifetime Data Anal       Date:  2018-02-28       Impact factor: 1.588

4.  Precision Medicine.

Authors:  Michael R Kosorok; Eric B Laber
Journal:  Annu Rev Stat Appl       Date:  2019-03       Impact factor: 5.810

5.  Adaptive Enrichment Designs in Clinical Trials.

Authors:  Peter F Thall
Journal:  Annu Rev Stat Appl       Date:  2021-03       Impact factor: 7.917

6.  Optimal two-stage dynamic treatment regimes from a classification perspective with censored survival data.

Authors:  Rebecca Hager; Anastasios A Tsiatis; Marie Davidian
Journal:  Biometrics       Date:  2018-05-18       Impact factor: 2.571

7.  On Estimation of Optimal Treatment Regimes For Maximizing t-Year Survival Probability.

Authors:  Runchao Jiang; Wenbin Lu; Rui Song; Marie Davidian
Journal:  J R Stat Soc Series B Stat Methodol       Date:  2016-09-02       Impact factor: 4.488

8.  Multi-Armed Angle-Based Direct Learning for Estimating Optimal Individualized Treatment Rules With Various Outcomes.

Authors:  Zhengling Qi; Dacheng Liu; Haoda Fu; Yufeng Liu
Journal:  J Am Stat Assoc       Date:  2019-04-11       Impact factor: 5.033

9.  Optimal treatment regimes for competing risk data using doubly robust outcome weighted learning with bi-level variable selection.

Authors:  Yizeng He; Soyoung Kim; Mi-Ok Kim; Wael Saber; Kwang Woo Ahn
Journal:  Comput Stat Data Anal       Date:  2021-01-14       Impact factor: 2.035

10.  On restricted optimal treatment regime estimation for competing risks data.

Authors:  Jie Zhou; Jiajia Zhang; Wenbin Lu; Xiaoming Li
Journal:  Biostatistics       Date:  2021-04-10       Impact factor: 5.899

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.